Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 5
1947 5
1948 6
1949 3
1950 4
1951 15
1952 25
1953 23
1954 23
1955 19
1956 23
1957 21
1958 20
1959 29
1960 19
1961 19
1962 19
1963 37
1964 77
1965 46
1966 37
1967 37
1968 62
1969 60
1970 55
1971 58
1972 87
1973 70
1974 88
1975 92
1976 71
1977 72
1978 59
1979 67
1980 65
1981 55
1982 53
1983 52
1984 56
1985 44
1986 44
1987 38
1988 44
1989 41
1990 31
1991 24
1992 30
1993 27
1994 20
1995 32
1996 17
1997 27
1998 15
1999 20
2000 29
2001 25
2002 24
2003 16
2004 25
2005 24
2006 25
2007 32
2008 32
2009 21
2010 30
2011 26
2012 37
2013 34
2014 30
2015 34
2016 29
2017 19
2018 19
2019 27
2020 23
2021 22
2022 17
2023 24
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

2,653 results

Results by year

Filters applied: . Clear all
Page 1
Malignant Hypertension: Current Perspectives and Challenges.
Boulestreau R, van den Born BH, Lip GYH, Gupta A. Boulestreau R, et al. J Am Heart Assoc. 2022 Apr 5;11(7):e023397. doi: 10.1161/JAHA.121.023397. Epub 2022 Mar 15. J Am Heart Assoc. 2022. PMID: 35289189 Free PMC article. Review.
Malignant hypertension.
Kincaid-Smith P. Kincaid-Smith P. J Hypertens. 1991 Oct;9(10):893-9. J Hypertens. 1991. PMID: 1658131 No abstract available.
Malignant hypertension: does this still exist?
Domek M, Gumprecht J, Lip GYH, Shantsila A. Domek M, et al. J Hum Hypertens. 2020 Jan;34(1):1-4. doi: 10.1038/s41371-019-0267-y. Epub 2019 Oct 21. J Hum Hypertens. 2020. PMID: 31636349 No abstract available.
Pharmacological management of malignant hypertension.
Lewek J, Bielecka-Dąbrowa A, Maciejewski M, Banach M. Lewek J, et al. Expert Opin Pharmacother. 2020 Jul;21(10):1189-1192. doi: 10.1080/14656566.2020.1732923. Epub 2020 Feb 26. Expert Opin Pharmacother. 2020. PMID: 32100590 Review.
Malignant Hypertension and Bilateral Primary Aldosteronism.
Murai S, Kakeshita K, Imamura T, Koike T, Fujioka H, Yamazaki H, Kinugawa K. Murai S, et al. Intern Med. 2023 Sep 15;62(18):2675-2680. doi: 10.2169/internalmedicine.1098-22. Epub 2023 Feb 1. Intern Med. 2023. PMID: 36725041 Free PMC article.
Malignant hypertension causing severe chorioretinopathy.
Basilious A, McInnis RL, Juncal VR. Basilious A, et al. Can J Ophthalmol. 2023 Aug;58(4):e160. doi: 10.1016/j.jcjo.2022.11.009. Epub 2022 Dec 5. Can J Ophthalmol. 2023. PMID: 36481184 No abstract available.
The pharmacological management of malignant hypertension.
Gosse P, Boulestreau R, Brockers C, Puel C, Rubin S, Cremer A. Gosse P, et al. J Hypertens. 2020 Nov;38(11):2325-2330. doi: 10.1097/HJH.0000000000002547. J Hypertens. 2020. PMID: 32649635 Review.
2,653 results